Jun

Drug derived from Gila monster saliva helps diabetics control glucose, lose weight

CHAPEL HILL – Exenatide, a drug that is a synthetic form of a substance found in Gila monster saliva, led to healthy sustained glucose levels and progressive weight loss among people with type 2 diabetes who took part in a three-year study.

Taking folic acid does not reduce risk of precancerous colon tumors

CHAPEL HILL – Taking folic acid supplements does not reduce the risk of developing precancerous tumors in the colon and may even increase the risk, a new study has found.

Genetic defect links respiratory disease and congenital heart disease

CHAPEL HILL – The same genetic defect that causes a rare respiratory disease may also lead to some types of congenital heart disease, according to a study from the University of North Carolina at Chapel Hill School of Medicine.

Most North Carolinians support law to eliminate tobacco use on school campuses

CHAPEL HILL – Ninety percent of North Carolina adults support the passage of a statewide law mandating a 100 percent tobacco-free policy in all N.C. school districts, according to a survey conducted in April and May by the Tobacco Prevention and Evaluation Program at the University of North Carolina at Chapel Hill.

Tobacco-Free Colleges Initiative has successful first year, UNC evaluation finds

CHAPEL HILL - A new program aimed at reducing tobacco use among North Carolina college students was successful in its first year of operation, according to an evaluation by UNC-Chapel Hill researchers.